ERNST TIMOTHY S
Known title: EVP, General Counsel & SecCIK: 0001676291
Associated companies
Transaction History
| BIO | ▲ Buy | Option Exercise | 2,500 | $815K | 2/28/2024 | View on chart |
| BIO | ▼ Sell | Open Market | 2,500 | $826K | 2/28/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 500 | $0 | 9/4/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 248 | $98K | 9/4/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 464 | $0 | 9/3/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 231 | $91K | 9/3/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 361 | $0 | 9/2/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 179 | $71K | 9/2/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 347 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 173 | $68K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 253 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 126 | $50K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 2,350 | $508K | 8/30/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 391 | $154K | 8/30/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 1,582 | $626K | 8/30/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 377 | $149K | 8/30/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 300 | $115K | 8/23/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 850 | $135K | 3/8/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 150 | $32K | 3/8/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 1,000 | $486K | 3/8/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 746 | $363K | 3/8/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 500 | $0 | 9/5/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 248 | $119K | 9/5/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 500 | $0 | 9/4/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 248 | $119K | 9/4/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 464 | $0 | 9/3/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 161 | $77K | 9/3/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 361 | $0 | 9/2/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 125 | $60K | 9/2/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 253 | $0 | 9/1/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 88 | $43K | 9/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth
The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.